相似文献
1
Current status of allergen immunotherapy (hyposensitization): memorandum from a WHO/IUIS meeting.
Bull World Health Organ. 1989;67(3):263-72.
2
Current status of allergen immunotherapy (hyposensitization). Report of a WHO/IUIS working Group.
Allerg Immunol (Leipz). 1989;35(4):235-47.
3
The current status of allergen immunotherapy (hyposensitisation). Report of a WHO/IUIS working group.
Allergy. 1989 Aug;44(6):369-79. doi: 10.1111/j.1398-9995.1989.tb04167.x.
4
[Hyposensitization: indications and expectations].
Padiatr Padol. 1990;25(6):397-404.
5
[Status report on allergen immunotherapy (hyposensitisation). Prepared by the WHO/IUIS Immunotherapy Subcommittee 1988].
Ugeskr Laeger. 1989 Nov 27;151(48):3249-52.
6
[Current aspects of hyposensitization].
HNO. 1990 Jul;38(7):233-41.
7
Local reactions from subcutaneous allergen immunotherapy.
Immunotherapy. 2013 Dec;5(12):1339-45. doi: 10.2217/imt.13.143.
8
9
Immunological mechanisms of allergen-specific immunotherapy.
Nat Rev Immunol. 2006 Oct;6(10):761-71. doi: 10.1038/nri1934.
10
Allergen-related approaches to immunotherapy.
Pharmacol Ther. 2009 Mar;121(3):273-84. doi: 10.1016/j.pharmthera.2008.11.007. Epub 2008 Dec 7.
引用本文的文献
1
Isotype-selective abrogation of established IgE responses.
Clin Exp Immunol. 1990 Dec;82(3):429-34. doi: 10.1111/j.1365-2249.1990.tb05466.x.
2
Long-lived reciprocal regulation of antigen-specific IgE and IgG2a responses in mice treated with glutaraldehyde-polymerized ovalbumin.
Immunology. 1991 Aug;73(4):407-14.
本文引用的文献
1
Antibody response following prolonged hyposensitization with Dermatophagoides pteronyssinus extract.
Int Arch Allergy Appl Immunol. 1980;61(4):431-40. doi: 10.1159/000232471.
2
A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results.
J Allergy Clin Immunol. 1982 Nov;70(5):343-52. doi: 10.1016/0091-6749(82)90023-9.
3
Subpopulations of circulating B cells and regulatory T cells involved in in vitro immunoglobulin E production in atopic patients with elevted serum immunoglobulin E.
J Clin Invest. 1980 Jun;65(6):1457-68. doi: 10.1172/JCI109810.
4
Production and testing of an international reference standard of short ragweed pollen extract.
J Allergy Clin Immunol. 1984 Jun;73(6):790-800. doi: 10.1016/0091-6749(84)90449-4.
5
Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.
J Allergy Clin Immunol. 1983 Oct;72(4):376-85. doi: 10.1016/0091-6749(83)90503-1.
6
Dose response of IgE and IgG antibodies during ragweed immunotherapy.
J Allergy Clin Immunol. 1984 Jan;73(1 Pt 1):94-104. doi: 10.1016/0091-6749(84)90490-1.
7
A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects.
Clin Allergy. 1984 May;14(3):209-19. doi: 10.1111/j.1365-2222.1984.tb02200.x.
8
IgG4 as a blocking antibody.
Clin Rev Allergy. 1983 Jun;1(2):289-302. doi: 10.1007/BF02991163.
9
Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses.
J Allergy Clin Immunol. 1984 Sep;74(3 Pt 1):230-9. doi: 10.1016/0091-6749(84)90251-3.
Zotero 插件